This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1097/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73091523
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в листопаді 1996 artículu científicu espublizáu en payares de 1996 scientific article published on 01 November 1996 wetenschappelijk artikel im November 1996 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q73091523-4C4FFB9A-A4C5-4F56-BD83-B4E17BA58713
wdt:P577
1996-11-01T00:00:00Z
p:P2093
wds:Q73091523-21F1B1A1-B9D1-46F7-B111-8E7D60643ABB wds:Q73091523-DDB30956-6B13-4668-9C5B-42A10699EF43 wds:Q73091523-8F400AEF-416C-42AB-8DF3-0D313C2E2A67
wdt:P2093
Gabrilovich DI Cunningham HT Carbone DP
rdfs:label
IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer
skos:prefLabel
IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer
schema:name
IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer
p:P1476
wds:Q73091523-8CCFA6D3-0EA7-4291-909A-1C2E7F68024E
wdt:P1476
IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer
p:P304
wds:Q73091523-9DC40AFE-C1A1-4B54-9B34-2EFF3BE89418
wdt:P304
414-418
p:P31
wds:Q73091523-6200A2F8-C14B-441F-8222-F55955AF165D
wdt:P31
wd:Q13442814
p:P921
wds:Q73091523-5E9E05C0-EC10-4E49-B14C-C725A8511AB7 wds:Q73091523-88BB0308-D4B3-4919-8E8E-D32B4EE09F92
wdt:P921
wd:Q1427096 wd:Q506253
p:P698
wds:Q73091523-B6E69D61-C67B-4713-A1DF-D7B021F6D4F2
wdtn:P698
n10:9041460
wdt:P698
9041460
p:P1433
wds:Q73091523-2A7ADC10-8D48-42F8-93C1-6E14D5227075
wdt:P1433
wd:Q27714027
p:P433
wds:Q73091523-E1FA40B1-2E28-4C11-9327-4F7C45B13509
p:P478
wds:Q73091523-04DB12C2-9D64-44F8-B286-2089CB6E90F7
wdt:P433
6
wdt:P478
19
p:P356
wds:Q73091523-F4143719-5D0C-4D06-9672-276F64334779
wdtn:P356
n12:00002371-199611000-00005
wdt:P356
10.1097/00002371-199611000-00005